Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2NET 1Endocrine 1

Conditions

Glioma 6Glioblastoma 3Insulinoma 2Hypoglycemia 2Hyperinsulinism 2Congenital Hyperinsulinism 2Brain Neoplasms 2Sarcoma 1Pheochromocytoma 1Parkinsonian Disorders 1Parkinson Disease 1Oligodendroglioma 1Neuroendocrine Tumors 1Neuroblastoma 1Neoplasms 1Lewy Body Disease 1Infant, Newborn, Diseases 1Glucose Metabolism Disorders 1Gliosarcoma 1Glioma, Subependymal 1Ependymoma 1Endocrine System Diseases 1Carcinoma, Medullary 1Carcinoid Tumor 1Beckwith-Wiedemann Syndrome 1Astrocytoma 1

Interventions

Radiosurgery 50Magnetic Resonance Spectroscopy 34Temozolomide 28Bevacizumab 24pembrolizumab 23Radiotherapy 20Nivolumab 20Specimen Handling 14Ipilimumab 13Cyclophosphamide 13Mental Status and Dementia Tests 12Carboplatin 12abemaciclib 10Radiation 10trastuzumab deruxtecan 8Proton Therapy 7Pemetrexed 7Memantine 7Blood Specimen Collection 7fluciclovine F-18 6binimetinib 6Paclitaxel 6Lomustine 6Etoposide 6Cisplatin 6Capecitabine 6encorafenib 5Trastuzumab 5Surveys and Questionnaires 5Surgical Procedures, Operative 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Brain Neoplasms × fluorodopa F 18 × 1 year × Clear all
NCT06667726 2026-04-28

An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors

Mayo Clinic

Phase 2 Recruiting
47 enrolled
CNS

Brain Neoplasms

NCT04706910 2026-02-09

18F-DOPA II - PET Imaging Optimization

University of Alberta

Phase 3 Recruiting
800 enrolled
CNSEndocrineNET

Brain Neoplasms, Neuroblastoma, Parkinson Disease, Neuroendocrine Tumors, Lewy Body Disease, Congenital Hyperinsulinism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡